Xiaoding Tan

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Yale University14.8%
• WuXi AppTec (China)10.6%
• Jiangsu T-mab BioPharma (China)10.6%
• King Abdulaziz City for Science and Technology7%
• Bioscience (China)7%
• Zhejiang Chinese Medical University5.6%
• Other44.4%

Fields

• Medicine85%
• Biochemistry, Genetics and Molecular Biology7.5%
• Chemistry2.5%
• Immunology and Microbiology2.5%
• Materials Science2.5%

Topics

• HER2/EGFR in Cancer Research29.8%
• Monoclonal and Polyclonal Antibodies Research24.5%
• CAR-T cell therapy research9.6%
• Radiopharmaceutical Chemistry and Applications6.4%
• Cancer Immunotherapy and Biomarkers5.3%
• Peptidase Inhibition and Analysis4.3%
• Other20.2%